EUROLYSE IVS: Financial statements 2019
CVR: 36462191
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 100. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 100
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 0 | 0 | 100 | - |
| 2018 | - | 0 | 0 | 100 | - |
| 2017 | - | 0 | 0 | 100 | - |
| 2016 | - | 0 | 0 | 100 | - |
| 2015 | - | 0 | 0 | 100 | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
EUROLYSE IVS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK 0.
About EUROLYSE IVS
EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.